Renal outcomes in metformin users versus non-metformin users in veterans with type 2 diabetes mellitus (T2DM).

被引：0
|
作者：
Gosmanova, E.
Canada, R. B.
Mangold, T. A.
Rawls, W. N.
Wall, B. M.
机构：
[1] VAMC, Memphis, TN USA
[2] Univ Texas, Hlth Sci Ctr, Memphis, TN USA
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2007年 / 49卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
70
引用
收藏
页码：A42 / A42
页数：1
相关论文
共 50 条
  • [21] Acute myopathy in a patient with type 2 diabetes (T2DM) receiving metformin, fenofibrate and rosiglitazone
    Ledl, MA
    Hohenecker, J
    Francesconi, C
    Roots, I
    Bauer, MF
    Roden, M
    DIABETES, 2005, 54 : A520 - A521
  • [22] Ramate as add-on to metformin (MET) in obese subjects with type 2 diabetes (T2DM)
    Toplak, H
    Vercruysse, F
    Sun, X
    Fitchet, M
    INTERNATIONAL JOURNAL OF OBESITY, 2004, 28 : S159 - S159
  • [23] Benefits beyond glycemia of adding rosiglitazone rather than glyburide to metformin monotherapy in type 2 diabetes mellitus (T2DM)
    Rood, JA
    Ryan, CM
    Cobitz, AR
    Waterhouse, BR
    Strachan, MWJ
    DIABETES, 2004, 53 : A480 - A480
  • [24] Time To Add-On Medication Use for Patients with Type 2 Diabetes Mellitus (T2DM) Who Failed Metformin Monotherapy
    Qiu, Ying
    Fu, Alex Z.
    Radican, Larry
    DIABETES, 2010, 59 : A70 - +
  • [25] TIME TO ADD-ON MEDICATION USE FOR PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) WHO FAILED METFORMIN MONOTHERAPY
    Qiu, Y.
    Fu, A. Z.
    Radican, L.
    VALUE IN HEALTH, 2010, 13 (07) : A299 - A299
  • [26] Metformin for Type 2 diabetes mellitus
    MacDonald, Blair J.
    Turgeon, Ricky D.
    McCormack, James
    ACADEMIC EMERGENCY MEDICINE, 2024, 31 (08) : 832 - 834
  • [27] Insulin plus metformin for T2DM—are there benefits?
    Clifford J. Bailey
    Nature Reviews Endocrinology, 2012, 8 : 449 - 450
  • [28] Metformin safety in T2DM patients with psoriasis
    Reactions Weekly, 2019, 1743 (1) : 10 - 10
  • [29] Empagliflozin (EMPA) for ≥76 Weeks As Add-on to Metformin in Patients with Type 2 Diabetes (T2DM)
    Merker, Ludwig
    Haering, Hans-Ulrich
    Christiansen, Anita Vedel
    Roux, Flavien
    Salsali, Afshin
    Kim, Gabriel
    Meinicke, Thomas
    Woerle, Hans-Juergen
    Broedl, Uli C.
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [30] Empagliflozin (EMPA) for ≥76 Weeks as Add-on to Metformin in Patients with Type 2 Diabetes (T2DM)
    Merker, Ludwig
    Haering, Hans-Ulrich
    Christiansen, Anita Vedel
    Roux, Flavien
    Salsali, Afshin
    Kim, Gabriel
    Meinicke, Thomas
    Woerle, Hans J.
    Broedl, Uli C.
    DIABETES, 2014, 63 : A278 - A278
12345